UK MHRA Spells Out Do's And Don'ts Of Real-World Evidence For Showing Efficacy
Executive Summary
A senior UK regulator explains why the MHRA agreed to a complex real-world evidence study instead of an RCT to demonstrate a drug's efficacy, despite the challenges posed by potential for bias.